Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Co-Diagnostics Inc (NASDAQ: CODX) closed at $0.41 in the last session, up 3.04% from day before closing price of $0.39. In other words, the price has increased by $3.04 from its previous closing price. On the day, 2.16 million shares were traded. CODX stock price reached its highest trading level at $0.4183 during the session, while it also had its lowest trading level at $0.374.
Ratios:
We take a closer look at CODX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.83 and its Current Ratio is at 4.12. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
On December 29, 2021, Sidoti started tracking the stock assigning a Buy rating and target price of $14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CODX now has a Market Capitalization of 24424826 and an Enterprise Value of 3985323. For the stock, the TTM Price-to-Sale (P/S) ratio is 42.84 while its Price-to-Book (P/B) ratio in mrq is 0.36. Its current Enterprise Value per Revenue stands at 3.971 whereas that against EBITDA is -0.106.
Stock Price History:
The Beta on a monthly basis for CODX is 1.17, which has changed by -0.6559322 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, CODX has reached a high of $1.55, while it has fallen to a 52-week low of $0.23. The 50-Day Moving Average of the stock is 1.65%, while the 200-Day Moving Average is calculated to be 4.23%.
Shares Statistics:
According to the various share statistics, CODX traded on average about 25.22M shares per day over the past 3-months and 123115010 shares per day over the past 10 days. A total of 60.14M shares are outstanding, with a floating share count of 53.75M. Insiders hold about 10.64% of the company’s shares, while institutions hold 8.55% stake in the company. Shares short for CODX as of 1760486400 were 111948 with a Short Ratio of 0.00, compared to 1757894400 on 795088. Therefore, it implies a Short% of Shares Outstanding of 111948 and a Short% of Float of 0.25.
Earnings Estimates
The stock of Co-Diagnostics Inc (CODX) is currently being evaluated by 1.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.16 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.79 and -$0.79 for the fiscal current year, implying an average EPS of -$0.79. EPS for the following year is -$0.39, with 1 analysts recommending between -$0.39 and -$0.39.
Revenue Estimates
According to 1 analysts,. The current quarter’s revenue is expected to be $300k. It ranges from a high estimate of $300k to a low estimate of $300k. As of. The current estimate, Co-Diagnostics Inc’s year-ago sales were $641.14kFor the next quarter, 1 analysts are estimating revenue of $300k. There is a high estimate of $300k for the next quarter, whereas the lowest estimate is $300k.
A total of 1 analysts have provided revenue estimates for CODX’s current fiscal year. The highest revenue estimate was $813k, while the lowest revenue estimate was $813k, resulting in an average revenue estimate of $813k. In the same quarter a year ago, actual revenue was $3.92MBased on 1 analysts’ estimates, the company’s revenue will be $1.35M in the next fiscal year. The high estimate is $1.35M and the low estimate is $1.35M.
